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ABSTRACT: A 15-year-old female African lion (Panthera leo) maintained at the Zoological Garden of Pistoia, 
Tuscany (Italy), showed signs of malaise, dyspnoea, tremors, pale mucous membranes and ataxia for two days prior 
to death. Complete blood count showed anaemia, thrombocytopaenia and severe lymphocytosis. At autopsy, the 
most relevant finding was severe, generalised splenomegaly. Histologically, high numbers of neoplastic lympho-
cytes diffusely infiltrated the spleen, liver, heart, pancreas, kidney and lungs. The lymphoid cells were positive 
for CD79a and negative for CD3 on immunohistochemistry. The histologic features of the neoplastic cells and 
their immunophenotype are consistent with B-cell lymphocytes. Based on surface membrane co-expression of 
immunoglobulin M and immunoglobulin D in most neoplastic cells, which indicated that they were naïve, antigen-
inexperienced and mature circulating resting B-cells, and consistent with their appearance as small lymphocytes 
with high nuclear-to-cytoplasmic ratios, a diagnosis of B-cell chronic lymphocytic leukaemia was made.
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Neoplasms of the haematopoietic system are 
commonly seen in domestic animals; malignant 
lymphomas have been extensively studied in do-
mestic canids and felids, but there is limited infor-
mation on malignant lymphomas in non-domestic 
animals (Gabor et al. 1998; Harrison et al. 2010).
Exotic felids in captivity, particularly African li-
ons (Panthera leo), are rarely diagnosed with ma-
lignant lymphoma and only three cases of T-cell 
chronic lymphocytic leukaemia have been report-
ed so far (Harrison et al. 2010). These animals were 
males and had weight loss, anaemia, lymphocytosis 
and splenomegaly. Although lymphomas in domes-
tic felids have been associated with feline leukae-
mia virus and feline immunodeficiency virus, there 
is only one documented case of lymphoma in a 
captive African lion that was concurrently infected 
with feline lentivirus (Harrison et al. 2010; Helfand 
and Kisseberth 2010; Vezzali et al. 2010).
In veterinary medicine, as in humans, haemat-
opoietic neoplasms are classified as myeloid or lym-
phoid on the basis of histogenesis and are divided 
into acute and chronic forms, based on clinical pres-
entation and the proliferative rate of the neoplastic 
cell clone (Tordiffe et al. 2013). Acute leukaemias are 
clonal proliferations of a progenitor cell with limited 
differentiation; therefore, identification of cellular 
markers is often necessary for definitive identifi-
cation of the cell of origin. In chronic leukaemias, 
neoplastic cells are terminally differentiated, and the 
cellular origin is more readily identifiable (Gabor et 
al. 1998). The primary laboratory finding in chronic 
lymphocytic leukaemia is leucocytosis caused by an 
absolute lymphocytosis. In domestic cats, lympho-
cyte counts varying from 36 000 to 250 000/l have 
been reported and haematological findings could 
include anaemia, thrombocytopaenia, neutropaenia 
and neutrophilia. Animals with thrombocytopaenia 
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are predisposed to haemorrhage owing to decreased 
platelet numbers and abnormal cell function (Valli 
et al. 2000).
Case description
We describe herein a case of B-cell chronic lym-
phocytic leukaemia in a 15-year-old female African 
lion (Panthera leo), maintained at the Zoological 
Garden of Pistoia, Tuscany (Italy). In October 2015, 
the lioness displayed signs of malaise, dyspnoea, 
tremors, pale mucus membranes and ataxia for two 
days. The lioness was anaesthetised with a com-
bination of 500 mg of tiletamine and zolazepam 
(Zoletil®, Virbac, France) with addition of 7 mg 
of detomidine (Domosedan®, Pfizer, USA) for di-
agnostic evaluation. Full anaesthesia was reached 
25 minutes after injection and lasted for one hour. 
Ultrasonographic examination of the abdomen re-
vealed diffuse, uniform and severe splenomegaly. 
Complete blood cell count results were anaemia 
and severe lymphocytosis. Biochemical indicators 
were elevated concentrations of urea and alanine 
aminotransferase, while albumin and glucose con-
centrations were low (Table 1). ELISA tests for fe-
line immunodeficiency virus, feline leukaemia virus 
(SNAP® FIV/FeLV Combo Plus Test, IDEXX, USA) 
and Dirofilaria immitis (SNAP® 4Dx® Test, IDEXX, 
USA) were negative. Two days after the investiga-
tion, the lioness died.
Pathological findings. An autopsy was per-
formed at the Zoological Garden of Pistoia. Samples 
of various organs were fixed in 10% buffered for-
malin and sent for histologic examination at the 
Experimental Zooprophylactic Institute of Lazio 
and Tuscany. The samples were embedded in par-
affin, sectioned at 5 µm, and stained with haema-
toxylin-eosin (H&E). Immunohistochemistry was 
performed with CD3 (Dako, UK), CD79a (Dako, 
UK) and CD20 (thermo Fisher Scientific, USA) an-
tibodies at a dilution of 1 : 600 to establish wheth-
er the neoplastic cells were of T- or B-cell origin. 
Furthermore, anti-immunoglobulin M (goat anti-
cat IgM, Biorad, USA) and anti- immunoglobulin D 
(rabbit polyclonal anti-IgD, Zeta Corporation, 
USA) antibodies were both used at a dilution of 
1 : 200 in immunohistochemistry staining to evalu-
ate the state of eventual activation of the B-cells, 
necessary to make a more precise diagnosis of the 
neoplastic form. Positive immunohistochemical 
controls included a normal feline lymph node. For 
negative controls, the primary antibodies were re-
placed with homologous non-immune sera.
The most relevant finding during gross examina-
tion was a severe generalised splenomegaly. The 
spleen had rounded edges, was dark purple and was 
very dense. It weighed 7.5 kg (nearly 20 times its 
normal size) and was 110 cm high × 50 cm long × 
20 cm wide. Other findings included pale mucos-
ae, pale kidneys, pulmonary congestion associated 
with areas of lung parenchyma consolidation, mild 
catarrhal enteritis and numerous ovarian cysts; a 
small mass of increased toughness was observed in 
uterus. All lymph nodes appeared normal.
Histologically, large numbers of neoplastic lym-
phocytes diffusely infiltrated the spleen, liver, heart, 
pancreas, kidney and lung. The most prominent 
infiltrates were seen in the spleen (60% involve-
ment), concentrated in the red pulp, with atrophy 
of lymphoid follicles (Figure 1). Massive infiltration 
of neoplastic cells was observed in liver sinusoids 
and, to a lesser extent, between the cardiac muscle 
fibres and around the pancreatic acini. Neoplastic 
cells consisted of small atypical lymphoid cells 
(6.5/7.5 µm) with small nuclei (high nuclear-to-cy-
toplasm ratio), an absence of nucleoli and coarsely 
Table 1. Haematological and biochemical values
Parameter Value Reference range*
Red blood count 4.5 6.05–9.99 × 1012/l
Haemoglobin 9.0 9.81–16.79 g/dl
Thrombocytes 60 120–430 × 109/l
White blood count 150.8 5.75–21.47 × 109/l
Lymphocytes 82.9 0.0–4.1 × 109/l
Monocytes 0.75 0.0–1.21 × 109/l
Alp 5 0.0–49.32 U/l
Alt 139.5 5.26–100.74 U/l
Urea 5.7 5.83–17.73 mmol/l
Creatinine 330 141.4–336.6 µmol/l
Total protein 78 64.0–86.1 g/l
Albumin 17 25.75–40.25 g/l
Globulin 60 29.33–54.67 g/l
Calcium 1.01 1.43–3.47 mmol/l
Phosphorus 6.8 5.5 mg/dl
Sodium 143 136.4–165.6 mmol/l
Glucose 15 122 mg/dl
Potassium 6.5 3.49–5.31 mmol/l
*Reference ranges were calculated using the International 
Species Information System (ISIS) database values (Teare 
1999) for lions
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90% of the neoplastic cells were positive for CD79a 
(Figure 2). The neoplastic lymphoid proliferation was 
classified using the current veterinary and human 
WHO classification of haematopoietic neoplasms 
(Valli et al. 2000; Vezzali et al. 2010).
In this case, the lioness showed typical signs of 
chronic lymphocytic leukaemia, including weight 
loss, splenomegaly, anaemia and marked lympho-
cytosis. Unfortunately, we were unable to obtain the 
bone marrow for evaluation. A massive infiltration 
of neoplastic cells was observed in liver sinusoids. 
Despite not having bone marrow, this favours clas-
sification as a leukaemia. Moreover, thrombocyto-
paenia indicates an important presence of neoplastic 
cells in the bone marrow. The massive infiltration of 
the spleen and other organs, and the features of the 
neoplastic cells, suggests that the lioness was affect-
ed by chronic lymphocytic leukaemia. The CD79a-
positivity and CD3-negativity provide evidence 
that the leukaemia was primarily B-cell in origin. 
In particular, according to reports (Caligaris-Cappio 
et al. 1993), the accumulation in different organs of 
naïve, antigen-inexperienced, well-differentiated B 
lymphocytes that circulate in the resting state, is 
considered a typical mark of B-CLL.
DISCUSSION AND CONCLUSIONS
Malignant lymphoma is the most common malig-
nant neoplasm diagnosed in domestic cats, while 
aggregated chromatin and moderate amounts of pale 
cytoplasm. These cells, in many areas of organ infil-
tration, resembled normal lymphocytes, although 
slightly smaller. These neoplastic cells showed a low 
mitotic index (0 and 1 mitoses/HPF). In addition, 
membranoproliferative glomerulonephritis and 
chronic interstitial pneumonia, with areas of scleros-
ing alveolitis, were observed, along with lymphop-
lasmacytic enteritis and leiomyoma in the uterus. 
In lymph nodes, depletion of lymphoid follicles was 
observed. Immunohistochemically, most of the lym-
phoid cells showed characteristic cell membrane 
CD79a positivity and negativity for CD3. The B-cell 
marker CD20, used in this study, does not cross-react 
with African lion lymphocytes. Furthermore, B-cells 
showed a constant co-expression of immunoglobulin 
M and immunoglobulin D on their surface mem-
branes, which usually marks naïve B-cells. Indeed, 
the view that B-cell chronic lymphocytic leukaemia 
(B-CLL) cells are antigen-naïve and resting but ma-
ture, is consistent with their appearance in tissue 
infiltrates, as small lymphocytes with a high nuclear-
to-cytoplasmic ratio (Bennett et al. 1989). These im-
munohistochemistry findings were observed in all 
organs, with particular evidence in the spleen, where 
Figure 1. Spleen of an African lion with chronic lympho-
cytic leukaemia. (A) Neoplastic lymphocytes diffusely 
replacing most of the normal splenic cell population. 
Haematoxylin and eosin (H&E). Bar = 200 μm. (B) 
Higher magnification; a detailed view of the charac-
teristic features of atypical lymphocytes. Neoplastic 
cells consisted of small atypical lymphoid cells (6.5/7.5 
µm) with small nuclei (moderate N/C ratio), absence of 
nucleoli and coarsely aggregated chromatin and moder-
ate amounts of pale cytoplasm. Haematoxylin and eosin 
(H&E). Bar = 20 μm
Figure 2. Spleen of an African lion with chronic lym-
phocytic leukaemia. (A) Neoplastic lymphocytes are 
immunoreactive for CD79a antibody. Bar = 100 μm. (B) 
At higher magnification, characteristic cell membrane 
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chronic lymphocytic leukaemia (CLL) is rare (Tebb 
et al. 2004). Exotic felids in captivity, particularly 
African lions, are rarely diagnosed with malignant 
lymphomas or CLL (Hruban et al. 1992; Owston et 
al. 2008; Valli 2010). Eleven cases of malignant lym-
phoma in African lions were described, and only 
one case was described as a diffuse large B-cell lym-
phoma (Harrison et al. 2010). The literature sug-
gests that chronic lymphocytic leukaemia is most 
commonly of T-cell origin in exotic felids; the aeti-
ology and pathogenesis in humans, dogs, cats and 
lions remains unknown. Neither feline leukaemia 
virus nor feline immunodeficiency virus, important 
causes of malignant lymphoma in domestic cats, 
are likely to be significant in the pathogenesis of 
malignant lymphoma in African lions (Poli et al. 
1995; Callanan et al. 1996; Harrison et al. 2010).
Chronic lymphocytic leukaemia (CLL) is a com-
mon condition that typically affects geriatric human 
beings (Binet et al. 1981). In T-CLL cells, now called 
T-cell prolymphocytic leukaemia (Catovsky et al. 
2001), a co-occurrence of high levels of CD3 antigen 
together with low levels of the B-cell surface anti-
gens CD19, CD20 and CD23 is described (Moreau et 
al. 1997). The levels of the surface immunoglobulin 
CD20 were characteristically very low compared with 
those found on normal B-cells (Ginaldi et al. 1998).
The CD79a protein is present on the surface of 
B-cells throughout their life cycle and is also pre-
sent in virtually all B-cell neoplasms; however, it is 
absent on all other healthy cells, making it a highly 
reliable marker for B-cells in immunohistochem-
istry. The B-cell marker CD20 is more commonly 
retained on mature B-cell lymphomas, so that the 
two are often used together in immunohistochem-
istry panels (Leong et al. 2003). In contrast, B-CLL 
cells typically express high levels of CD20, CD79a 
and surface Ig (Catovsky et al. 2001). Regarding 
surface Ig expression, B-CLL cells are generally na-
ïve, antigen-inexperienced mature B lymphocytes 
that circulate in the resting state (Caligaris-Cappio 
et al. 1993), and their characteristic surface mem-
brane co-expression of immunoglobulin M and 
immunoglobulin D, indicates their status as “vir-
gin” B-cells (Coffman and Cohn 1977). Also, in the 
present case, B-CLL was diagnosed on the basis of 
ubiquitous B-cell marker CD79a immunochemistry 
expression, and surface membrane co-expression 
of immunoglobulin M and immunoglobulin D; 
unfortunately, the B-cell marker CD20 does not 
cross-react with lioness lymphocytes.
The numerous statistics published on CLL have 
revealed a certain number of prognostic factors. 
The importance of sex, age, the degree of periph-
eral lymphocytosis, the degree of associated anaemia 
or thrombocytopaenia, cutaneous manifestations, 
signs of inflammation and the onset of a sarcoma 
have all been stressed but it has not been possible to 
determine the relative importance of each of these 
(Binet et al. 1981). In humans, CLL is a neoplasm 
composed of monomorphic small B lymphocytes 
in the peripheral blood, bone marrow, spleen and 
lymph nodes that form proliferation centres in tissue 
infiltrates (Helfand and Kisseberth 2010). In CLL, 
B-cells exhibit uncontrolled proliferation and ac-
cumulate in the bone marrow and blood, crowding 
out healthy red or white blood cells and platelets. 
Asymptomatic people are often diagnosed after lym-
phocytosis is noted in a routine complete blood cell 
count; a marrow aspirate and biopsy generally are 
not required for the diagnosis (Hallek et al. 2008).
CLL in cats, where the disease appears most of-
ten, is characterised by small cells with round nuclei 
typically 1 to 1.5 red blood count in diameter with 
a very narrow rim of cytoplasm. Leukaemia would 
be expected to involve multiple tissues and in those 
interpreted to be true leukaemia, both acute lympho-
cytic leukaemia and CLL were more likely widely dis-
tributed, which attests to the utility of liver aspiration 
as an adjunct to examination of blood and marrow 
in the diagnosis of leukaemia (Vezzali et al. 2010).
Although CLL is a systemic disease, collections 
of pale cells known as proliferation centres, which 
are newly formed structures, and have not been 
described in reactive lymphadenitis or other lym-
phoproliferative conditions, can be found. The cells 
in these collections are also malignant cells but 
are somewhat larger and mitotically active. In the 
current case, no lymph node involvement was ob-
served, like in domestic cats, and the lioness was 
negative for feline leukaemia virus and feline im-
munodeficiency virus; therefore, the aetiology of 
the leukaemia is unknown.
To our knowledge, this is the first case of B-cell 
chronic lymphocytic leukaemia reported in an 
African lion (Panthera leo).
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